Roche Taps AI to Find Lung Cancer Patients After Trial Success

Roche Holding AG’s lung cancer drug scored a big win against a standard therapy in a study this week. Now, the Swiss drugmaker is turning to artificial intelligence to find patients who can benefit.

Related Keywords

China ,Japan ,Switzerland ,Madrid ,Spain ,Israel ,Israeli ,Swiss ,Levi Garraway ,Roche Alecensa ,Charlie Fuchs ,Medial Earlysign Ltd ,Roche Holding ,European Society For Medical Oncology ,Chief Medical Officer Levi Garraway ,Medial Earlysign ,European Society ,Medical Oncology ,Roche ,Ai ,Lung Cancer Drug ,Lung Cancer ,Surgery ,Chemotherapy ,Ai Collaboration ,Data Algorithms ,